A Clinically Guided Approach To Weight Management
Explore a medically supervised weight management programme using semaglutide, a GLP-1 receptor agonist that can support appetite regulation and weight management when prescribed appropriately.
Treatment Overview
Semaglutide works primarily through the GLP-1 pathway, which plays a role in appetite, food intake, blood glucose regulation, and digestion. By influencing these processes, semaglutide may help eligible patients manage appetite and support weight reduction as part of a broader medical weight management programme.
Your treatment begins with a physician-led assessment of your medical history, current medications, weight-related health factors, lifestyle, and treatment goals. If semaglutide is considered appropriate, your clinician will establish an individualised treatment and monitoring plan.
Programme Options
Choose the programme duration that best fits your planned treatment and follow-up schedule:
4 Weeks
A structured introductory programme with clinical monitoring as you begin treatment.
6 Weeks
Extended support allowing additional time for treatment monitoring and review.
8 Weeks
Continued medical supervision with ongoing assessment of your progress and treatment response.
10 Weeks
Extended support for clients requiring a longer period of structured clinical monitoring.
12 Weeks
A comprehensive three-month programme providing continued medical oversight and weight management support.
Programme length refers to the duration of your selected package. It does not determine your medication dose. Semaglutide dosing is individualised and may be gradually adjusted by your prescribing clinician based on your response and tolerability.
Key Benefits
✓ Physician-led weight management
✓ Individualised semaglutide treatment planning
✓ Appetite and weight management support
✓ Structured clinical monitoring
✓ Regular assessment of treatment response
✓ Lifestyle and weight management guidance
Ideal For
• Adults seeking medically supervised weight management
• Individuals who may be clinically appropriate for semaglutide
• Clients experiencing challenges with appetite or weight management
• Individuals seeking a structured medical approach to weight reduction
• Clients looking for ongoing clinical support alongside lifestyle changes
What To Expect
Your programme begins with a comprehensive medical assessment. Your health history, current medications, relevant medical conditions, previous weight management efforts, lifestyle, and treatment goals will be reviewed.
If semaglutide is clinically appropriate, your prescribing clinician will determine your starting dose and treatment schedule. Your progress, response, and tolerability will be monitored throughout your programme, with adjustments made where clinically indicated.
Ongoing Monitoring
Weight management medication requires ongoing clinical supervision. Follow-up appointments may be used to assess weight changes, appetite, treatment response, side effects, and overall progress.
Your treatment plan may be adjusted over time based on your individual response and clinical needs.
Important Safety Information
Semaglutide is a prescription medication and is not appropriate for everyone. It has important contraindications, warnings, and potential adverse effects that will be discussed during your medical assessment.
Common adverse effects may include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. Your clinician will review your medical history and medications to determine whether semaglutide is appropriate for you.
Consultation Required
A medical weight management consultation is required before semaglutide can be prescribed. Treatment is only initiated following clinical assessment and confirmation that it is appropriate for you.
